Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis appoints Onaiza Cadoret-Manier as chief corporate development and commercial officer

CARLSBAD, Calif. , Jan. 9, 2020 /PRNewswire/ —  Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, today announced the appointment of Onaiza Cadoret-Manier as chief corporate development and commercial officer reporting to Brett P.